SR

Smita Rani Acharya

Active Director Director DIN 10138222
DIN 10138222 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Smita Rani Acharya

Data last updated:

Smita Rani Acharya is a Director at Medicinexa Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10138222
Primary Designation Director
Industry Pharma
First Appointment 28 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20232023Active

Board colleagues of Smita Rani Acharya

NameDINCompanyDesignation
Asis Kumar Kar10138223Medicinexa Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medicinexa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Smita Rani Acharya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smita Rani Acharya

Smita Rani Acharya currently holds 1 directorship: Medicinexa Pharmaceuticals Private Limited (Director, since 28 Apr 2023).

Smita Rani Acharya was first appointed on 28 Apr 2023 as Director at Medicinexa Pharmaceuticals Private Limited.

The current boards of Smita Rani Acharya's companies include Asis Kumar Kar (Medicinexa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available